[Mortality and beta-agonists, or the risk of statistical inference]

Arch Bronconeumol. 2007 Jul;43(7):355-7. doi: 10.1016/s1579-2129(07)60085-8.
[Article in Spanish]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenergic beta-Agonists / adverse effects*
  • Data Interpretation, Statistical
  • Humans
  • Risk
  • Safety

Substances

  • Adrenergic beta-Agonists